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TO THE EDITOR
Xeroderma pigmentosum (XP) is an
inherited human disorder in which
patients have greatly elevated inci-
dence of solar-induced cancers caused
by mutations in genes for nucleotide
excision repair or polymerase Z that are
required for repair or replication of
damaged DNA (Hoeijmakers, 2001;
Wood et al., 2001; Cleaver and Mitchell,
2006). We report a cluster of XP-C
patients within an isolated Guatemala
community containing a new mutation.
A recently diagnosed US XP-C patient
was also analyzed for comparison and
found to be a compound heterozygote
for two novel mutations in the XPC
gene.
A Guatemala village containing
many XP patients was identified by
missionaries from Good Samaritans
International, in consultation with phy-
sicians in Guatemala City. Among a
total of about 50 children, approxi-
mately 12 had evidence of photosensi-
tivity, severe poikloderma, and multiple
non-melanoma skin cancers. Their tu-
mors were often advanced, showing
necrosis and infection and the children
suffered continual pain from sun ex-
posure. There was no evidence of
neurological symptoms seen in the XP
patients identified, such as hearing loss
and ataxia (Cleaver and Mitchell,
2006). However, the majority of the
affected children do not live beyond
their 10th birthday and later findings of
neurological degeneration would not
be identified. There were no reported
skin cancers among parents. According
to oral tradition, the village originated
in a common family approximately 100
years ago. Intermarriage is high and we
hypothesized that the XP patients
would be homozygous for the same
mutation in an XP gene (see Table 1).
Blood samples were obtained from a
male patient (XP202BA), his father
(XP211BA), and one other father
(XP212BA) of an XP patient who was
not directly related. Blood samples
were also obtained from a newly
diagnosed US patient seen at the Uni-
versity of California San Francisco
(UCSF) (XP207SF). This patient was a
2-year-old female born of non-consan-
guineous parents who had extensive
facial freckling and a small squamous
cell carcinoma on the bridge of the
nose that was biopsied for diagnosis.
The purpose of the sample collection
was carefully explained to donors and
parents under the terms of a current
UCSF Committee on Human Research
permit and the Declaration of Helsinki
Principles. Parents of subjects con-
sented to blood draws in Guatemala
via translators in the presence of the
local health official and documentation
was retained by their physicians. Lym-
phocytes were transformed by Epstein–-
Barr virus infection and permanent
lymphoblastoid cell lines were estab-
lished and given UCSF designations. A
previously classified XP-C lymphoid
cell line (GM02498) was obtained from
the Coriell Cell Repository (Camden,
NJ) and a normal cell line (PPO34)
from a UCSF bank. Fibroblast cultures
were obtained from the UCSF patient
and for GM02498 (GM00676 orAbbreviation: CSF, University of California San Franciso; XP, xeroderma pigmentosum.
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XP9BE) (Robbins et al., 1974), but
could not be obtained for the Guate-
malan patients. UV sensitivity was
determined by irradiation with increas-
ing doses of UV light (254 nm,
1.3 J m2 second), growth for 7 days,
followed by counting the total surviving
cell number, a method previously
shown equivalent to colony formation
(Cleaver and Thomas, 1988). From the
survival curve, the values of the dose
for 50% survival was determined (Ta-
ble 1). The UV sensitivities of the
XP202BA and XP207SF cell lines were
close to that of the standard XP-C cell
line (GM02498) (see D50 values in
Table 1). These sensitivities combined
with the absence of neurological symp-
toms were suggestive of XP group C.
Western blot analysis was carried
out using an antibody to XPC (Abcam
ab6264, Abcam, Cambridge, MA) fol-
lowed by anti-mouse antibody conju-
gated to horseradish peroxidase.
XP202BA, XP207SF, and GM02498
lacked detectable full-length protein,
whereas similar protein levels were
seen in normal and XP-D cell lines
(Figure 1a). Immunohistochemical ana-
lysis of a fixed tumor from another
Guatemalan patient was also negative
for XPC (to be reported later).
The XPC gene was sequenced using
the PCR-ready primer pairs (Variant-
SEQr) from Applied Biosystems (AB,
Foster City, CA) that amplified each
exon and flanking regions from geno-
mic DNA and data were analyzed using
their custom software (Table 1). Direct
sequencing of the PCR products from
the UCSF patient, XP207SF, detected a
complex heterozygote with two differ-
ent mutations: one was in exon 3 (a
single base pair deletion) (Figure 1b)
and the other in exon 4 (a two base pair
deletion) (Figure 1c), resulting in over-
lapping sequences downstream of the
mutations. These both resulted in chain
terminations and predicted truncated
protein products (Figure 1e). No other
mutations were detected, so we assume
that these two mutations occurred in
the two different alleles. Direct sequen-
cing of XP202BA identified a deletion
of a single base pair in exon 8, with no
downstream overlapping sequences,
that caused a frameshift and premature
termination (Figure 1d and e).
The presence of a single mutant
sequence in DNA from the pro-
band could indicate homozygosity or
hemizygosity for the -c deletion. We
resolved these alternatives by determin-
ing the copy numbers of the wild-type
and deletion sequences using real-time
PCR (Taqman analysis). Probes were
designed to detect the wild-type (-ccc-)
and deleted (-cc-) sequences in exon 8,
and copy numbers determined against a
pool of ovarian DNA (Table 2). As the
target sequences differed by only one
base, discrimination of wild-type and
mutant sequences was not complete,
but adequate to distinguish the two
alternatives. The normal control,
PPO34, and XP207SF both showed
high relative copy numbers for the
normal sequence, as expected for di-
ploid DNA content. The heterozygote
XP211BA showed a similar copy num-
ber for mutant and wild-type se-
quences. XP202BA showed a signal
for mutant sequence approximately
double that of the heterozygote, and
low signal for wild-type sequence. This
result is consistent with the proband
containing two copies of the mutant
sequence, and not with a complete
deletion of one allele. The proband is
therefore homozygous for the -c dele-
tion in exon 3.
The deletion was present in the
heterozygous form in both fathers of
XP children resulting in overlapping
sequences downstream of the deletion
(Figure 1d). As the mutations could not
be unambiguously identified from the
sequence of the PCR products when
both a wild-type and mutant sequence
were present, we subcloned the PCR
products via TA-TOPO cloning (Invitro-
gen, Carlsbad, CA) and resequenced to
confirm the mutations (Figure 1f). The
mutations in XP202BA and XP207SF
have not been reported before (Cha-






(J m2) Allele 1 Allele 2
XP202BA Proband (Guatemala) 8 1.2 (n=4) Exon 8, C940del-1, 969 stop Same
XP211BA Father of XP202BA Adult 6.6 (n=1) Exon 8, C940del-1, 969 stop Wild-type
XP212BA Father of another XP child Adult 7.5 (n=1) Exon 8, C940del-1, 969 stop Wild-type
XP207SF (UDS 32.1%)2 Proband (UCSF) 2 0.65 (n=3) Exon 3, A362del-1, 438 stop Exon 4, GA444, 445 del-2, 498 stop
XP9BE3 (UDS 10–20%)2 Coriell repository 16 1.2 (n=1) Exon 11, GTG2092ins3 Same and Exon 16, A2815C
Normal (PPO34) UCSF Adult 8.2 (n=4) Wild-type Wild-type
UCSF, University of California San Francisco; UDS, unscheduled DNA synthesis; XP, xeroderma pigmentosum.
All nucleotide numbers refer to the coding DNA sequence (CDS) described in Genbank NM_004628 in which exons are numbered sequentially 1–16.
1The UV survival curves from these lymphoid cells were exponential (linear on a semi-log plot). The UV sensitivity is therefore unambiguously defined by the
slope, which is designated here by the dose for 50% survival. The survival curves are represented by the formula: ‘‘Relative survival=exp(D/1.443D50)’’, for
the relative survival at dose D where D50 is the dose required for 50% survival in units of J m
2. The value ‘‘n’’ represents the number of independent survival
curves determined to obtain the D50 value.
2Unscheduled DNA synthesis (Robbins et al., 1974). These values are typical of XP-C and we expect the Guatemalan cells to be similar (Cleaver and
Mitchell, 2006).
3This insertion was previously reported and confirmed by our sequencing. We also identified the non-conservative A2815C (lysine to glutamine) in exon 16
in one allele that had been previously reported in this cell line as A2920C in exon 15 using nomenclature in which our exons 5 and 6 is annotated as exons
5.1 and 5.2 (Khan et al., 2000, 2002).
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vanne et al., 2000; Khan et al., 2002,
2004, 2006), and each cause loss of
protein and consequent failure in nu-
cleotide excision repair. The novelty of
the Guatemalan mutation is, however,
insufficient to decide whether the XPC
mutation is newly derived or of im-
migrant origin.
The high incidence of XP in this
village is most likely due to the
immigration of a single individual



































Figure 1. Protein expression and sequence analysis of XPC. (a) Western analysis of cell extracts probed by anti-XPC mAb (Abcam ab6264). Cell line
complementation groups designated where known. (b) DNA sequence within the regions of XPC exon 3 for wild-type PP034 and XP207SF showing Adel and
wild-type sequence overlapping downstream of the deletion (accession number DQ076467). (c) DNA sequence within the regions of XPC exon 4 for wild-type
PP034 and XP207SF showing GAdel and wild-type sequence overlapping downstream of the deletion (accession number DQ076476). (d) DNA sequence within
the regions of XPC exon 8 showing C940del. Top to bottom: wild-type, XP202BA, XP211BA, XP212BA. The presence of two sequences can be seen as
overlapping sequences downstream from the deletion in both of the heterozygous samples (accession number DQ076464). (e) Predicted translation products
in XPC showing normal sequences (black), frameshift (gray), and amino-acid sites of mutations and downstream termination for XP202BA and XP207SF.
(f) Subcloned sequences showing mutations from XP211BA exon 8, XP207SF exon 3, and XP207SF exon 4. Subcloned exon sequences identified mutations
in five of nine clones for XP207SF exon 3; three of six clones in XP207SF exon 4; one of six in XP211BA; and two of six in XP211BA.
Table 2. Relative copy number of exon 3 sequences normalized to an
ovarian DNA pool
Mutant sequence -cc- Wild-type sequence -ccc-
Cell line Observed Ratios1 Observed Ratios1
Normal (PPO34) 0.11 0.35 0.76 1.9
XP207SF 0.12 0.39 0.78 2.0
XP211BA 0.31 1 0.4 1
XP202BA 0.59 1.9 0.07 0.18
1Normalized to heterozygote values of 1.0 for each allele.
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spread through the population owing to
intermarriage. A similar ‘‘founder ef-
fect’’ has been reported for XP else-
where. XP patients in Tunisia show
homozygosity for an exon 6 mutation,
R228ter, in XPA (Nishigori et al., 1993).
Many XP patients in Japan have the
same splice site mutation in XPA
(Satokata et al., 1992). Two families in
Italy and Turkey were found to have
common descent with the same muta-
tion in XPC (Gozukara et al., 2001).
This disease presents a major health
crisis to an extremely isolated commu-
nity. They are subsistence coffee farm-
ers, very distant from health services,
and bringing care to the patients and
families presents major difficulties. The
clinical conditions are severe, with life-
threatening cancers and associated in-
fectious disease, such that patients die
in their early teenage years. This is in
contrast to XP-C patients in the USA
who can modify their life-styles to
avoid sun exposure and achieve a near
normal lifespan.
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